HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ikko Kajihara Selected Research

Infliximab (Remicade)

1/2019Infliximab improved the refractory cutaneous involvement in a patient with dermatomyositis.
7/2017S100A7 expression levels in coordination with interleukin-8 indicate the clinical response to infliximab for psoriasis patients.
5/2016Enhanced CCR9 expression levels in psoriatic skin are associated with poor clinical outcome to infliximab treatment.
4/2016Symptomless Pulmonary Cryptococcosis in a Psoriatic Arthritis Patient during Infliximab Therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ikko Kajihara Research Topics

Disease

22Neoplasms (Cancer)
09/2023 - 05/2014
19Systemic Scleroderma (Systemic Sclerosis)
06/2022 - 02/2012
16Fibrosis (Cirrhosis)
01/2024 - 02/2012
14Psoriasis (Pustulosis Palmaris et Plantaris)
10/2023 - 04/2013
13Melanoma (Melanoma, Malignant)
11/2022 - 01/2016
10Extramammary Paget Disease (Paget Disease, Extramammary)
09/2023 - 02/2015
10Hemangiosarcoma (Angiosarcoma)
10/2021 - 02/2015
8Dermatomyositis (Dermatopolymyositis)
01/2019 - 09/2011
6Autoimmune Diseases (Autoimmune Disease)
05/2020 - 04/2012
5Collagen Diseases (Collagen Disease)
05/2020 - 09/2011
5Systemic Lupus Erythematosus (Libman-Sacks Disease)
08/2017 - 10/2012
3Erythema
03/2023 - 08/2017
3Squamous Cell Carcinoma (Epidermoid Carcinoma)
02/2022 - 11/2020
3Cicatrix (Scar)
08/2017 - 09/2013
3Ulcer
08/2017 - 09/2013
3Rheumatic Diseases (Rheumatism)
10/2015 - 07/2012
3Localized Scleroderma (Morphea)
09/2013 - 01/2013
2Hemangioma (Angioma)
03/2023 - 09/2018
2Microsatellite Instability
05/2022 - 02/2022
2Dermatofibrosarcoma
05/2022 - 04/2018
2Circulating Neoplastic Cells
01/2022 - 02/2019
2Neoplasm Metastasis (Metastasis)
07/2021 - 02/2019
2Pemphigus (Pemphigus Vulgaris)
01/2021 - 08/2017
2Psoriatic Arthritis
09/2020 - 04/2016
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
05/2020 - 04/2015
2Sclerosis
01/2020 - 04/2013
2Carcinogenesis
05/2019 - 10/2017
2Hypoxia (Hypoxemia)
02/2019 - 06/2014
2Cutaneous Fistula
03/2014 - 04/2013
1Alopecia Areata
04/2024
1Skin Diseases (Skin Disease)
04/2024
1Radiation induced angiosarcoma of the breast
02/2024
1Amyopathic dermatomyositis
01/2023
1Necrosis
01/2023
1Inflammation (Inflammations)
09/2021
1Lymphatic Metastasis
07/2021
1Merkel Cell Carcinoma
11/2020
1Behcet Syndrome (Behcet's Syndrome)
11/2020

Drug/Important Bio-Agent (IBA)

13CollagenIBA
06/2022 - 02/2012
12DNA (Deoxyribonucleic Acid)IBA
10/2023 - 07/2012
12MicroRNAs (MicroRNA)IBA
09/2023 - 04/2012
11Biomarkers (Surrogate Marker)IBA
04/2024 - 11/2013
11Proteins (Proteins, Gene)FDA Link
10/2021 - 11/2015
8CytokinesIBA
04/2024 - 02/2012
8Cell-Free Nucleic AcidsIBA
04/2024 - 09/2020
7Bleomycin (Blenoxane)FDA LinkGeneric
06/2022 - 04/2013
6Messenger RNA (mRNA)IBA
09/2023 - 05/2013
4Collagen Type I (Type I Collagen)IBA
01/2024 - 04/2012
4Immune Checkpoint InhibitorsIBA
09/2021 - 12/2016
4Infliximab (Remicade)FDA Link
01/2019 - 04/2016
4EnzymesIBA
07/2017 - 09/2011
3LigandsIBA
10/2023 - 05/2020
3Interleukin-8 (Interleukin 8)IBA
10/2023 - 07/2017
3Interleukin-23 (Interleukin 23)IBA
01/2023 - 01/2017
3Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
11/2022 - 04/2020
3AntigensIBA
02/2021 - 12/2016
3Docetaxel (Taxotere)FDA Link
01/2020 - 02/2015
3Silver Sulfadiazine (SSD)FDA LinkGeneric
10/2015 - 09/2013
3ImmunosorbentsIBA
09/2013 - 09/2011
2Janus Kinase 2IBA
01/2023 - 07/2021
2Small Interfering RNA (siRNA)IBA
06/2022 - 11/2020
2alpha2 Subunit Collagen Type IIBA
06/2022 - 09/2015
2PromegaIBA
05/2022 - 02/2022
2Peptides (Polypeptides)IBA
02/2021 - 01/2020
2Interleukin-17 (Interleukin 17)IBA
02/2021 - 04/2012
2AntibodiesIBA
10/2020 - 07/2012
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
09/2020 - 01/2014
2AutoantibodiesIBA
08/2020 - 05/2020
2Paclitaxel (Taxol)FDA LinkGeneric
01/2019 - 02/2015
2Transforming Growth Factors (Transforming Growth Factor)IBA
11/2017 - 01/2013
2IntegrinsIBA
09/2015 - 01/2013
1TrabectedinIBA
02/2024
1ChemokinesIBA
10/2023
1Heat-Shock Proteins (Heat-Shock Protein)IBA
09/2023
1Propranolol (Inderal)FDA LinkGeneric
03/2023
1Janus KinasesIBA
03/2022
1Circulating MicroRNAIBA
01/2022
1Circulating Tumor DNAIBA
01/2022
1Early Growth Response Protein 1IBA
09/2021
1Lactic Acid (Lactate)FDA LinkGeneric
09/2021
1Nucleosomes (Nucleosome)IBA
04/2021
1EpitopesIBA
02/2021
1ParaffinIBA
02/2021
1Tumor Viral Antigens (Large T Antigen)IBA
11/2020
1avelumabIBA
11/2020
1Transcription Factors (Transcription Factor)IBA
11/2020
1Prednisolone (Predate)FDA LinkGeneric
11/2020
1HLA-A*26 antigenIBA
11/2020
1SurvivinIBA
10/2020

Therapy/Procedure

19Therapeutics
03/2023 - 02/2015
3Combination Drug Therapy (Combination Chemotherapy)
01/2020 - 02/2015
2Aftercare (After-Treatment)
03/2023 - 02/2021
2Immunotherapy
02/2021 - 01/2020
2Radiotherapy
05/2020 - 01/2019
2Negative-Pressure Wound Therapy
03/2014 - 04/2013
2Skin Transplantation (Skin Grafting)
03/2014 - 04/2013
1Laser Therapy (Surgery, Laser)
03/2023
1Duration of Therapy
03/2023
1Cell- and Tissue-Based Therapy (Cell Therapy)
02/2021
1Injections
02/2021